Weed (BUDZ) Cash from Operations Growth (1y) (2011 - 2026)
Weed (BUDZ) Cash from Operations Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.15 Bn | 87.28 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.89 Bn | 32.15 Bn | 1.97 Bn | 61.90% |
| 3 | Zoetis | 32.49 Bn | 30.55 Bn | 1.62 Bn | -22.14% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.50 Bn | 4.39 Bn | 8.20% |
| 5 | United Therapeutics | 23.20 Bn | 21.05 Bn | 648.10 Mn | 0.46% |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | -27.49% |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.43 Bn | 800.70 Mn | 125.00% |
| 9 | Elanco Animal Health | 12.58 Bn | 12.15 Bn | 785.00 Mn | 425.00% |
| 10 | Weed | 2.77 Mn | 2.77 Mn | - | 19.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.63% |
| Dec 31, 2025 | 6.10% |
| Sep 30, 2025 | 82.70% |
| Jun 30, 2025 | 101.61% |
| Mar 31, 2025 | 59.58% |
| Dec 31, 2024 | 62.50% |
| Sep 30, 2024 | 93.66% |
| Jun 30, 2024 | 22.78% |
| Mar 31, 2024 | -0.31% |
| Dec 31, 2023 | -88.54% |
| Sep 30, 2023 | -136.17% |
| Jun 30, 2023 | 59.27% |
| Mar 31, 2023 | 2.56% |
| Dec 31, 2022 | -142.44% |
| Sep 30, 2022 | -65.24% |
| Jun 30, 2022 | -194.13% |
| Mar 31, 2022 | 37.43% |
| Dec 31, 2021 | 50.87% |
| Sep 30, 2021 | -4.74% |
| Jun 30, 2021 | -29.94% |